Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Royal Bank of Canada 

Chemed Corp. diskutieren

Chemed Corp.

WKN: A0CBF4 / Symbol: CHE / Name: Chemed / Aktie / Anbieter & Dienstleistungen / Mid Cap /

535,00 €
-0,93 %

Einschätzung Buy
Rendite (%) -1,68 %
Kursziel 568,73
Veränderung
Endet am 30.10.24

Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $576.00 to $604.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,82 %
Kursziel 575,75
Veränderung
Endet am 17.01.25

Chemed Co. (NYSE: CHE) had its price target raised by analysts at Oppenheimer Holdings Inc. from $590.00 to $625.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,57 %
Kursziel 600,54
Veränderung
Endet am 28.02.25

Chemed Co. (NYSE: CHE) had its price target raised by analysts at Oppenheimer Holdings Inc. from $625.00 to $650.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat

Einschätzung Buy
Rendite (%) -11,11 %
Kursziel 655,25
Veränderung
Endet am 04.03.25

Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $604.00 to $712.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat

Chemed Co. (NYSE: CHE) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for CHE provided by MarketBeat